Skip to main content
. 2022 Jun 29;36(1):5–13. doi: 10.2337/ds21-0108

Table 1.

Participant Demographics (N = 60)

Category Responses
Mean age, years 61
Male sex 30 (50)
Race/ethnicity
White/Caucasian
Hispanic/Latino
Native American/American Indian
Black/African American
Asian/Pacific Islander
Other
Preferred not to answer

39 (65)
11 (18.3)
2 (3.3)
2 (3.3)
1 (1.7)
2 (3.3)
3 (5)
No previous use of a non–GLP-1 receptor agonist injectable agent 34 (56.7)
Education
College, graduate level
College, undergraduate level
High school
Less than high school

22 (36.7)
19 (31.7)
15 (25)
4 (6.7)
English as first language 56 (93.3)
Diabetes duration, years
>10
6–10
1–5
<1 year or unknown

21 (35)
12 (20)
21 (35)
6 (10)
NVS health literacy score
0–1 (limited)
2–3 (possibly limited)
4–6 (adequate)

10 (16.7)
12 (20)
38 (63.3)

Data are n (%) unless otherwise noted.